Alladapt Immunotherapeutics

About:

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

Website: https://www.alladapt.com/

Top Investors: Hercules Capital, Novartis, Patient Square Capital, Red Tree Venture Capital, Anne Wojcicki

Description:

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being advanced as a broad spectrum oral immunotherapy treatment to mitigate food allergy triggered by single or multiple proteins from an expansive set of common allergens.